$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Analysis of the duration of efficacy and influencing factors of rasagiline (Azila)
2026-02-01 22:25:32
Check Details
Analysis of the trade name of Sotoracib (AMG 510) and naming differences in different countries
2026-02-01 22:25:32
Check Details
Adagrasiib (Krazati) dose adjustment method and medication differences among different groups of people
2026-02-01 22:25:32
Check Details
Are there any taboos and dietary recommendations required while taking larotrectinib (Vitacai)?
2026-02-01 22:25:32
Check Details
Potential effects of selinexol (silvio) on the kidneys and dosage adjustment recommendations
2026-02-01 22:25:32
Check Details
Vigabatrin (Ocoda) blood concentration monitoring and dose adjustment methods
2026-02-01 22:25:32
Check Details
Is it safe to take Mobosetinib (Anvili) for a long time and what are the risks?
2026-02-01 22:25:32
Check Details
Tepotinib (Tuodekang) drug metabolism characteristics and interactions with other drugs
2026-02-01 22:25:32
Check Details
Why does Regorafenib (Belvango) adopt a 21-day on-take and 7-day-off cycle and analysis of the reasons
2026-02-01 22:25:32
Check Details
Clinical application of Pazopanib in the treatment of bone and soft tissue sarcoma
2026-02-01 22:25:32
Check Details
Opicapone dosage form and specification details and usage recommendations
2026-02-01 22:25:32
Check Details
How many months does Fenelidone (Keshenda) start to take effect and treatment planning suggestions?
2026-02-01 22:25:32
Check Details
1
2
...
2000
2001
2002
2003
2004
2005
2006
...
10226
10227
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
First CELMoD Drug Zenbexus Wins FDA Accelerated Approval for Multiple Myeloma
2
Elamipretide Side Effects and Medication Safety Guide: Injection Site Reactions and Storage Essentials
3
Dutasteride Soft Capsules: Comprehensive Side Effect Profile and Management Strategies
4
Oral Semaglutide Tablets: A Complete Guide to the GLP-1 Receptor Agonist for Type 2 Diabetes and Cardiovascular Protection
5
Sotorasib (Lumakras): A Comprehensive Guide to the First KRAS G12C-Targeted Inhibitor
6
Comprehensive Interpretation of Osimertinib: Efficacy, Side Effects and Medication Standards
7
Sotorasib: Can the First KRAS G12C-Targeted Therapy Cure Cancer?
8
Trametinib (Mekinist): Refrigerated Storage, Fasting Administration, and BRAF Mutation Indications Explained
9
Asciminib (SCEMBLIX): STAMP Inhibitor Dosing Guide and Nomenclature Clarification for CML
10
Belzutifan (Welireg): HIF-2α Inhibitor for VHL-Associated Tumors and Renal Cell Carcinoma — Dosing Phases, Survival Data, and Efficacy Insights
11
Cabergoline Medication Guide: Contraindications, Treatment Costs, and Safety Monitoring Essentials
12
Pemigatinib vs. Anlotinib: Key Differences Between FGFR-Targeted Therapy and Multi-Target Anti-Angiogenic Treatment